Does vitamin D require liver and kidney activation to support immune regulation and calcium handling?

Vitamin D is best characterized as a secosteroid prohormone: its principal endocrine activity depends on sequential liver and kidney conversion to calcitriol. The claim is well supported for this activation pathway, immune modulation, and calcium physiology; “cardiometabolic resilience” requires a narrower interpretation.

Activation and mechanisms

• Hepatic CYP2R1 converts vitamin D to 25-hydroxyvitamin D (calcidiol), then renal proximal-tubule CYP27B1 converts calcidiol to 1,25-dihydroxyvitamin D (calcitriol).
• Calcitriol binds intracellular vitamin-D receptor (VDR), which heterodimerizes with RXR and regulates target-gene transcription through vitamin-D response elements.
• This pathway is regulated: low ionized calcium raises PTH, stimulating CYP27B1; calcitriol feeds back to suppress CYP27B1. Liver disease and chronic kidney disease can therefore alter the availability of active hormone.

Immune and calcium effects

• Calcitriol directly modulates dendritic-cell maturation, T-cell priming/proliferation, cytokine programs, and IL-10/regulatory-T-cell-associated phenotypes. These are immunoregulatory—not broadly “immune-boosting”—actions; supplementation trials do not establish reliable disease-modifying benefit.
• Calcium regulation is a canonical effect. Intestinal VDR signaling increases TRPV6, calbindin-D9k, and PMCA1b, supporting calcium absorption and PTH–calcitriol feedback. Excess exposure can cause hypercalcemia; doses of 3,200–4,000 IU/day increased relative hypercalcemia risk in meta-analysis.

Cardiometabolic interpretation

• Cardiovascular prevention is not established: VITAL found no reduction in major cardiovascular events with vitamin D3 2,000 IU/day over ~5 years (HR 0.97, 95% CI 0.85–1.12).
• In established type 2 diabetes, especially with deficiency, meta-analyses suggest modest changes in HbA1c (−0.48%), fasting glucose (−0.46 mmol/L), and HOMA-IR (−0.39), with uncertain clinical magnitude.

Bottom line

• Vitamin D’s hormone-precursor role and its calcium and cellular immune-regulatory functions are well established. It should not, however, be viewed as a universal cardiovascular or cardiometabolic preventive therapy.